Policy of using M&A as a means of business expansion
First written in FY2016. 24 of 31 entries say "Advanced", first in FY2018-Q1. Latest entry: 2026-08-07.
8 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「As the company newly acquired shares in 株式会社テックインターナショナル, デルフィア株式会社 and 株式会社橋本薬局, these companies were included in the scope of consolidation from the current consolidated fiscal year.」
In addition to the acquisition and consolidation of テックインターナショナル, デルフィア and 橋本薬局, a business transfer was also carried out, advancing expansion of the business base through M&A. - FY2026-H1AdvancedAnnual report
「During the current interim consolidated accounting period, ㈱テックインターナショナル and デルフィア㈱ were included in the scope of consolidation following the acquisition of their shares, while マスターズフォレスト㈱ was included following its establishment.」
Expansion of the business base through M&A and newly established companies progressed through the acquisition of shares in テックインターナショナル and デルフィア and the consolidation of the newly established マスターズフォレスト. - FY2025-H1AdvancedAnnual report
「In addition, 株式会社ＭＯＮＡＫＡ was included in the scope of consolidation following the acquisition of additional shares.」
The acquisition and consolidation of ＭＯＮＡＫＡ advanced the policy of using M&A to expand the business, representing a new acquisition. - FY2024-Q3AdvancedAnnual report
「In addition, 株式会社エヌジェイメディカル was included in the scope of consolidation following the acquisition of additional shares.」
The acquisition and consolidation of 株式会社エヌジェイメディカル advanced the policy of using M&A to expand the business, representing a new acquisition. - FY2024-Q2AdvancedAnnual report
「In addition, 有限会社Ｃ.Ｍ.Ｊ and 有限会社フレンズ were included in the scope of consolidation following the acquisition of additional shares.」
The acquisition and consolidation of Ｃ.Ｍ.Ｊ and フレンズ were carried out, advancing the policy of using M&A to expand the business as a new acquisition. - FY2023-Q3AdvancedAnnual report
「During the third quarter of the consolidated fiscal year, ㈱オールケアー was included in the scope of consolidation following the newly acquired shares.」
The acquisition and consolidation of 株式会社オールケアー advanced the policy of using M&A to expand the business, representing a new acquisition. - FY2023-Q2RestatedAnnual report
「In accordance with the share transfer agreement, the company acquired the common shares of キングラン株式会社 on 1 July 2022 and made it a subsidiary.」
The completion of the acquisition of shares in キングラン and its consolidation as a subsidiary was reconfirmed in the detailed disclosure of the business combination. As this was not a newly completed acquisition, it was treated as a reconfirmation of existing progress. - FY2023-Q1AdvancedAnnual report
「In accordance with the share transfer agreement, the company acquired the common shares of キングラン株式会社 on 1 July 2022 and made it a subsidiary.」
The acquisition of shares in and consolidation of キングラン株式会社 as a subsidiary was completed, advancing the policy of using M&A to expand the business as a new acquisition. The voting-rights ratio after the acquisition was 98.0%. - FY2022AdvancedAnnual report
「At a meeting of its board of directors held on 27 April 2022, the company resolved to acquire shares in キングラン株式会社 and make it a subsidiary, and on the same date entered into a share transfer agreement for the shares in キングラン株式会社.」
The policy of using M&A to expand the business took concrete form through the board resolution and execution of the share transfer agreement to make キングラン株式会社 a subsidiary. - FY2022-Q2AdvancedAnnual report
「In the dispensing pharmacy business, performance remained solid as restrictions on visits to medical institutions eased compared with the same period of the previous year, supported by new store openings and M&A of small-format stores, among other factors.」
M&A involving small-format stores and new store openings were carried out, advancing the policy of using M&A to expand the business through further expansion of the business base. - FY2022-Q1AdvancedAnnual report
「In addition, 有限会社ケイツーファーマシー, 有限会社寿老会 and 株式会社ハッピーケア were included in the scope of consolidation following the acquisition of additional shares. マスターズホスピタリティ株式会社, which had been an equity-method affiliate through the previous consolidated fiscal year, was also included in the scope of consolidation based on the substantive control criterion.」
The company newly consolidated 3 companies through share acquisitions, and 1 former equity-method affiliate also moved into the scope of consolidation based on the substantive control criterion. Expansion of the business base through M&A and equity investments is progressing. - FY2021RestatedAnnual report
「The group considers M&A one means of expanding its business, and may require a significant amount of funding going forward.」
The policy of using M&A to expand the business has continued, and the company acquired and consolidated Myanmar medical equipment distributors and other companies during the period. - FY2021-Q3AdvancedAnnual report
「In addition, 有限会社カインドネス was included in the scope of consolidation following the acquisition of additional shares.」
The acquisition and consolidation of カインドネス advanced the policy of using M&A to expand the business, representing a new acquisition. This further expanded the scope of consolidation following the acquisition of the Myanmar companies in the first quarter and オオサカ薬局 in the second quarter. - FY2021-Q2AdvancedAnnual report
「During the second quarter consolidated accounting period, 株式会社オオサカ薬局 was included in the scope of consolidation following the acquisition of additional shares.」
The acquisition and consolidation of オオサカ薬局 advanced the policy of using M&A to expand the business, representing a new acquisition. - FY2021-Q1AdvancedAnnual report
「On 27 April 2020, the group acquired shares in Okkar Thiri Co.,Ltd., Myanmar’s largest medical equipment distributor, and Snow Everest Co.,Ltd., the country’s third-largest, making both companies consolidated subsidiaries.」
The company acquired additional shares in 2 Myanmar medical equipment distributors, in addition to its existing holdings, and made them consolidated subsidiaries with an 80.0% voting-rights ratio. Its policy of using M&A to expand the business was put into practice overseas. - FY2020AdvancedAnnual report
「The group has operated dialysis and CT services in the Republic of the Union of Myanmar (hereinafter, “Myanmar”) since 2014. To further expand its business by leveraging the experience and expertise it has built up, on 27 April 2020 it acquired shares in Okkar Thiri Co.,Ltd., Myanmar’s largest medical equipment distributor, and Snow Everest Co.,Ltd., the country’s third-largest, making both companies consolidated subsidiaries.」
On 27 April 2020, after the financial results announcement, the group acquired 2 medical equipment distributors in Myanmar, with the post-acquisition voting rights ratio reaching 80.0% at each company. The policy of using M&A as a means of expanding the business is taking concrete shape overseas. - FY2020-Q3AdvancedAnnual report
「During the third quarter of the consolidated fiscal year, ㈱日本ネットワークサービス, its subsidiary ㈱アネット, and ㈱ふれあい were included in the scope of consolidation following the newly acquired shares.」
日本ネットワークサービス and its affiliates were acquired and consolidated, representing new progress in the policy of using M&A as a means of expanding the business. - FY2020-Q2AdvancedAnnual report
「During the second quarter of the consolidated fiscal year, ㈱日本システム家具 and ㈱ジョイアップ were included in the scope of consolidation following the newly acquired shares.」
The acquisition of 日本システム家具 and ジョイアップ represents new progress in the policy of using M&A as a means of expanding the business. - FY2020-Q1AdvancedAnnual report
「In addition, ㈱I&C was included in the scope of consolidation following the newly acquired shares.」
Shares in ㈱I&C were acquired and the company was consolidated, representing concrete progress in the policy of using M&A as a means of expanding the business. - FY2019-Q3AdvancedAnnual report
「In the dispensing pharmacy business, the number of stores increased through new store openings and small-scale M&A,」
Small-scale M&A was carried out in addition to new store openings, increasing the number of stores. The policy of using M&A as a means of expanding the business is advancing as a concrete initiative. - FY2018AdvancedAnnual report
「In the dispensing pharmacy business, performance remained strong as operating efficiency improved following ongoing operational improvements and M&A proved effective.」
The policy of using M&A as a means of expanding the business has been confirmed as contributing to performance in the dispensing pharmacy business. - FY2018-Q3AdvancedAnnual report
「In addition, ㈲オルガンメディカル was included in the scope of consolidation following the newly acquired shares.」
Shares in オルガンメディカル were acquired and the company was consolidated, representing concrete progress in the policy of using M&A as a means of expanding the business. - FY2018-Q2RestatedAnnual report
「In the dispensing pharmacy business, performance remained strong as M&A and new store openings proved effective.」
The policy of using M&A as a means of expanding the business continues to be identified as contributing to performance in the dispensing pharmacy business. - FY2018-Q1AdvancedAnnual report
「During the first quarter of the consolidated fiscal year, ユーロメディテック㈱ and ㈲花梨薬局 were included in the scope of consolidation following the newly acquired shares.」
Shares in ユーロメディテック and 花梨薬局 were acquired and the companies were consolidated, representing concrete progress in the policy of using M&A as a means of expanding the business. - FY2017-Q3RestatedAnnual report
「In Other, revenue and profit increased because of M&A involving security companies and progress in the animal hospital business in line with the initial plan.」
M&A involving security companies continues to be identified as a factor behind higher revenue and profit in Other, reaffirming the policy of using M&A as a means of expanding the business. - FY2017-Q2RestatedAnnual report
「Revenue increased as a result of M&A and new store openings carried out in the previous fiscal year.」
The policy of using M&A as a means of expanding the business continues to be identified as a factor behind higher revenue in the dispensing pharmacy business. - FY2016First statedAnnual report
「The group considers M&A one means of expanding its business, and may require a significant amount of funding going forward.」
M&A is positioned as an ongoing means of expanding the business.